These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 16187178)

  • 1. Herbal medicines for liver diseases.
    Dhiman RK; Chawla YK
    Dig Dis Sci; 2005 Oct; 50(10):1807-12. PubMed ID: 16187178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of herbal supplements for chronic liver disease.
    Levy C; Seeff LD; Lindor KD
    Clin Gastroenterol Hepatol; 2004 Nov; 2(11):947-56. PubMed ID: 15551246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial drugs for liver diseases.
    Muriel P; Rivera-Espinoza Y
    J Appl Toxicol; 2008 Mar; 28(2):93-103. PubMed ID: 17966118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does herbal medicine reduce the risk of hepatocellular carcinoma?
    Rino Y; Yukawa N; Yamamoto N
    World J Gastroenterol; 2015 Oct; 21(37):10598-603. PubMed ID: 26457019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal medicine in the treatment of liver diseases.
    Stickel F; Schuppan D
    Dig Liver Dis; 2007 Apr; 39(4):293-304. PubMed ID: 17331820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.).
    Tamayo C; Diamond S
    Integr Cancer Ther; 2007 Jun; 6(2):146-57. PubMed ID: 17548793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in herbal medicine for treatment of liver diseases.
    Ghosh N; Ghosh R; Mandal V; Mandal SC
    Pharm Biol; 2011 Sep; 49(9):970-88. PubMed ID: 21595500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytotherapy and NAFLD--from goals and challenges to clinical practice.
    Milosević N; Milanović M; Abenavoli L; Milić N
    Rev Recent Clin Trials; 2014; 9(3):195-203. PubMed ID: 25514914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milk thistle (Silybum marianum) for the therapy of liver disease.
    Flora K; Hahn M; Rosen H; Benner K
    Am J Gastroenterol; 1998 Feb; 93(2):139-43. PubMed ID: 9468229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of plants used in the treatment of liver disease: part 1.
    Luper S
    Altern Med Rev; 1998 Dec; 3(6):410-21. PubMed ID: 9855566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the use of milk thistle (Silybum marianum).
    Post-White J; Ladas EJ; Kelly KM
    Integr Cancer Ther; 2007 Jun; 6(2):104-9. PubMed ID: 17548789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Milk thistle in liver diseases: past, present, future.
    Abenavoli L; Capasso R; Milic N; Capasso F
    Phytother Res; 2010 Oct; 24(10):1423-32. PubMed ID: 20564545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal hepatoprotective agents: marketing gimmick or potential therapies?
    Dhiman RK
    Trop Gastroenterol; 2003; 24(3):160-2. PubMed ID: 14978996
    [No Abstract]   [Full Text] [Related]  

  • 14. Herbal medicines for liver diseases in India.
    Thyagarajan SP; Jayaram S; Gopalakrishnan V; Hari R; Jeyakumar P; Sripathi MS
    J Gastroenterol Hepatol; 2002 Dec; 17 Suppl 3():S370-6. PubMed ID: 12472966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.
    Pradhan SC; Girish C
    Indian J Med Res; 2006 Nov; 124(5):491-504. PubMed ID: 17213517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silymarin: not just another antioxidant.
    Camini FC; Costa DC
    J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32134732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Liverubin™ on hepatic biochemical profile in patients of alcoholic liver disease: a retrospective study.
    Nanda V; Gupta V; Sharma SN; Pasricha A; Karmakar AK; Patel A; Bhatt VM; Kantroo BL; Kumar B; Paul NK; Attam R
    Minerva Med; 2014 Dec; 105(6 Suppl 2):1-8. PubMed ID: 26076375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis.
    El-Kamary SS; Shardell MD; Abdel-Hamid M; Ismail S; El-Ateek M; Metwally M; Mikhail N; Hashem M; Mousa A; Aboul-Fotouh A; El-Kassas M; Esmat G; Strickland GT
    Phytomedicine; 2009 May; 16(5):391-400. PubMed ID: 19303273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis C.
    Reddy KR; Belle SH; Fried MW; Afdhal N; Navarro VJ; Hawke RL; Wahed AS; Doo E; Meyers CM;
    Clin Trials; 2012 Feb; 9(1):102-12. PubMed ID: 22058086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milk thistle for the treatment of liver disease: a systematic review and meta-analysis.
    Jacobs BP; Dennehy C; Ramirez G; Sapp J; Lawrence VA
    Am J Med; 2002 Oct; 113(6):506-15. PubMed ID: 12427501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.